Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-05-29 @ 1:10 PM
Study NCT ID:
NCT00798369
Status:
COMPLETED
Last Update Posted:
2012-04-10
First Post:
2008-11-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CACZ885H2255
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
External Affairs
Old Organization:
Novartis Pharmaceuticals